Total Payments
$9,496
2024 Payments
$1,286
Companies
45
Transactions
548
Medicare Patients
28,752
Medicare Billing
$4.5M
Payment Breakdown by Category
Food & Beverage$9,450 (99.5%)
Education$45.85 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,450 | 545 | 99.5% |
| Education | $45.85 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,444 | 117 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,218 | 69 | $0 (2024) |
| Amgen Inc. | $1,172 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $575.61 | 20 | $0 (2024) |
| PFIZER INC. | $560.27 | 37 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $542.43 | 29 | $0 (2023) |
| Organogenesis Inc. | $391.49 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $346.93 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $309.50 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $295.55 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,286 | 44 | AstraZeneca Pharmaceuticals LP ($218.17) |
| 2023 | $903.89 | 51 | Novartis Pharmaceuticals Corporation ($260.46) |
| 2022 | $1,306 | 84 | Novartis Pharmaceuticals Corporation ($440.20) |
| 2021 | $1,734 | 109 | Janssen Pharmaceuticals, Inc ($379.23) |
| 2020 | $1,088 | 65 | Amgen Inc. ($310.56) |
| 2019 | $1,420 | 68 | Janssen Pharmaceuticals, Inc ($358.46) |
| 2018 | $1,070 | 71 | Gilead Sciences, Inc. ($149.77) |
| 2017 | $687.44 | 56 | Novartis Pharmaceuticals Corporation ($157.07) |
All Payment Transactions
548 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Obesity | ||||||
| 11/06/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: WOUND CARE | ||||||
| 11/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Obesity | ||||||
| 09/24/2024 | ConvaTec Inc. | AQUACEL AG+ (Device) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $178.57 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: Cardiovascular | ||||||
| 09/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Not Applicable | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | CashFlow Solutions, LLC | LYMPHA PRESS OPTIMAL PLUS(US) BT (Device), PCD-51 731A (US) - White, PCD-52 737A (US) White | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Pneumatic Compressor | ||||||
| 07/30/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/25/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.03 | General |
| 07/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Automated insulin delivery system | ||||||
| 07/10/2024 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological), EVKEEZA | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $133.72 | General |
| Category: VTE | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $63.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 9,223 | 14,308 | $4.9M | $1.4M |
| 2022 | 35 | 8,495 | 13,004 | $4.3M | $1.3M |
| 2021 | 31 | 6,896 | 11,586 | $3.5M | $1.1M |
| 2020 | 28 | 4,138 | 8,026 | $2.0M | $626,140 |
Total Patients
28,752
Total Services
46,924
Medicare Billing
$4.5M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 1,498 | 1,677 | $883,690 | $213,931 | 24.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 594 | 605 | $840,000 | $188,478 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 766 | 1,930 | $435,263 | $174,707 | 40.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 820 | 855 | $327,829 | $105,042 | 32.0% |
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance | Office | 2023 | 87 | 142 | $442,750 | $101,203 | 22.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 560 | 770 | $277,693 | $100,479 | 36.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 143 | 150 | $278,242 | $88,886 | 31.9% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 27 | 27 | $285,525 | $84,852 | 29.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 331 | 1,340 | $175,040 | $58,635 | 33.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 337 | 674 | $175,190 | $56,688 | 32.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 274 | 564 | $67,680 | $50,872 | 75.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 515 | 560 | $145,144 | $43,936 | 30.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 475 | 485 | $103,978 | $22,001 | 21.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 59 | 471 | $30,615 | $21,492 | 70.2% |
| 93985 | Complete ultrasound of artery and vein blood flow pre-op assessment on both sides of body for hemodialysis access | Office | 2023 | 115 | 115 | $61,464 | $20,033 | 32.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 104 | 107 | $55,784 | $17,491 | 31.4% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 554 | 559 | $56,828 | $14,875 | 26.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 607 | 1,181 | $64,917 | $12,266 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 85 | $30,175 | $9,649 | 32.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 105 | 105 | $26,250 | $9,277 | 35.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 126 | 126 | $21,694 | $6,095 | 28.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 88 | 144 | $40,320 | $5,275 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 76 | $12,008 | $5,016 | 41.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 40 | 41 | $15,836 | $4,807 | 30.4% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 19 | 20 | $11,261 | $3,294 | 29.2% |
About Dr. Daniel Bouknight, MD
Dr. Daniel Bouknight, MD is a Interventional Cardiology healthcare provider based in Irmo, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427057009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Bouknight, MD has received a total of $9,496 in payments from pharmaceutical and medical device companies, with $1,286 received in 2024. These payments were reported across 548 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($9,450).
As a Medicare-enrolled provider, Bouknight has provided services to 28,752 Medicare beneficiaries, totaling 46,924 services with total Medicare billing of $4.5M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Irmo, SC
- Active Since 07/18/2005
- Last Updated 06/27/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1427057009
Products in Payments
- XARELTO (Drug) $1,218
- Repatha (Biological) $1,089
- ENTRESTO (Drug) $1,017
- ELIQUIS (Drug) $860.79
- LEQVIO (Drug) $426.51
- MULTAQ (Drug) $393.56
- FARXIGA (Drug) $385.36
- JARDIANCE (Drug) $216.50
- VERQUVO (Drug) $205.60
- Barostim Neo System (Device) $192.81
- Puraply Antimicrobial (Medical Supply) $185.89
- Puraply (Medical Supply) $174.11
- LEXISCAN (Drug) $154.69
- PRALUENT (Drug) $148.87
- WATCHMAN (Device) $143.58
- NEXLETOL (Drug) $138.09
- FLOWTRIEVER CATHETER, S (Device) $133.72
- AQUACEL AG+ (Device) $114.34
- BRILINTA (Drug) $114.11
- ZONTIVITY (Drug) $102.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.